A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)

NCT05465785 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Pneumonia

Interventions

BIOLOGICAL: Recombinant COVID-19 vaccine (Sf9 cell)

Sponsor

WestVac Biopharma Co., Ltd.